Congress Asset Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-492,556
| Closed | -$1.15M | – | 388 |
|
|
2022
Q3 | $1.15M | Sell |
492,556
-48,571
| -9% | -$114K | 0.01% | 298 |
|
|
2022
Q2 | $1.64M | Buy |
541,127
+11,304
| +2% | +$34.3K | 0.02% | 292 |
|
|
2022
Q1 | $3.6M | Buy |
529,823
+148,777
| +39% | +$1.01M | 0.03% | 253 |
|
|
2021
Q4 | $3.18M | Buy |
381,046
+112
| +0% | +$935 | 0.02% | 253 |
|
|
2021
Q3 | $2.83M | Buy |
380,934
+22,535
| +6% | +$167K | 0.02% | 250 |
|
|
2021
Q2 | $2.44M | Buy |
358,399
+255,629
| +249% | +$1.74M | 0.02% | 259 |
|
|
2021
Q1 | $1.06M | Buy |
102,770
+10,420
| +11% | +$107K | 0.01% | 294 |
|
|
2020
Q4 | $646K | Sell |
92,350
-1,280
| -1% | -$8.95K | 0.01% | 299 |
|
|
2020
Q3 | $764K | Hold |
93,630
| – | – | 0.01% | 273 |
|
|
2020
Q2 | $646K | Buy |
93,630
+1,160
| +1% | +$8K | 0.01% | 276 |
|
|
2020
Q1 | $439K | Buy |
+92,470
| New | +$439K | 0.01% | 290 |
|